Rowley Law investigates XOMA Royalty acquisition

News provided by Rowley Law PLLC Apr 27, 2026, 15:06 ET Share this article Share to X Share this article Share to X NEW YORK , April 27, 2026 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by XOMA Royalty Corporation (NASDAQ: XOMA ) and its board of directors concerning the proposed acquisition of the company by Ligand Pharmaceuticals Incorporated (NASDAQ: LGND ). Stockholders will receive $39.00 and one contingent value right for each share of XOMA Royalty stock that they hold. The transaction is valued at approximately $739 million and is expected to close in the third quarter of 2026.

If you are a stockholder of XOMA Royalty Corporation and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/xoma/ . You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected] , or by telephone at 914-400-1920 or 844-400-4643 (toll-free). Rowley Law PLLC represents stockholders nationwide in class actions and derivative lawsuits in complex corporate litigation.

For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com . Attorney Advertising. Prior results do not guarantee a similar outcome.

SOURCE Rowley Law PLLC 21 % more press release views with Request a Demo × Modal title